| 
Home Page
Collaborative
Research Areas
Research Affiliates
Core Services
Behavioral Science Core
Brain Imaging Core
Cellular Morphology Core
Genetics Core
Animal Behavior Core
Instrument Development Laboratory Core
|
CHDD Research Domain:
Developmental and Molecular Genetics
Genetic factors account for a significant portion of developmental disabilities. Even
milder forms of developmental disability are increasingly known
to have a genetic basis. Although much progress has been made in
tracking genes responsible for various developmental disabilities,
much more knowledge is needed in order to prevent and treat genetically
related problems associated with a wide variety of disorders. CHDD
researchers are identifying genes, studying their molecular biology,
developing techniques for gene therapy, and evaluating pharmacological
intervention targets to specific genetic pathways.
Ongoing studies seek the identity
of genes associated with specific disorders including autism, learning
disabilities and hereditary neuropathies. Studies of the genetic
bases of deafness and epilepsy are also underway.
Studies of gene regulation mechanisms
involved in immune response are progressing at CHDD. Infants with
immature or failed immune systems are prey to infections that can
cause neurological impairment and intellectual and other developmental disabilities. Researchers
are investigating the association between abnormal immune system
function and abnormal central nervous system function and studying
the genetic factors involved.
Research is also focused on understanding
the cellular and molecular basis for neonates' susceptibility to
infection by intracellular pathogens such as herpes simplex virus,
Group B Streptococcus, tuberculosis and Listeria, which can have
significant neurologic consequences. The molecular basis for why
adult T cells protect against infectious agents more readily than
neonatal T cells is also of interest. Researchers studying pediatric
AIDS are working to develop therapeutic strategies to prevent the
transmission of HIV from mother to fetus.
Research continues on the common elements
of various neurodevelopmental disorders, including the hereditary
ataxias, caused by gene mutations called trinucleotide repeat expansions,
in which symptoms appear earlier and more severely from generation
to generation. Researchers are investigating the genetic and epigenetic
mechanisms underlying X-linked disorders, including fragile X syndrome,
the most common known inherited cause of intellectual and other developmental disabilities. Linkage
analysis studies and molecular cloning methods are being used to
locate genes that cause a number of inherited neurological disorders,
including Charcot-Marie-Tooth neuropathy and Disorders of Hindbrain Development. CHDD
researchers are also seeking the genetic bases of various forms
of craniofacial malformation and associated developmental problems and investigating the molecular basis of numerous neurodegenerative disorders.
Investigators:
| Kristina M. Adams Waldorf, M.D. |
206-667-7002 |
Obstetrics and Gynecology |
| Robert Andrews, M.D. |
206-667-4263 |
Pediatrics |
| Thomas
Benedetti, M.D. |
206-616-3789 |
Pediatrics |
| Thomas
Bird, M.D. |
206-543-2340 |
Neurology |
| Zoran Brkanac, M.D. |
206-543-9573 |
Psychiatry and Behavioral Sciences |
| Jeffrey Chamberlain, Ph.D. |
206-685-0964 |
Neurology, Biochemistry, and Medicine |
| Timothy
C. Cox, Ph.D. |
206-685-3412 |
Pediatrics |
| Michael
Cunningham, M.D., Ph.D. |
206-616-5277 |
Pediatrics |
| Daniel
Doherty, M.D., Ph.D. |
206-987-2489 |
Pediatrics |
| William B. Dobyns, M.D. |
206-884-1025 |
Pediatrics |
| Evan Eichler, Ph.D. |
206-543-9526 |
Genome Sciences |
| Elaine
Faustman, Ph.D. |
206-685-2269 |
Environmental and Occupational Health Sciences |
| Clement Furlong, Ph.D. |
206-543-1193 |
Medicine and Genome Sciences |
| Stanley
Gartler, Ph.D. |
206-543-1775 |
Genetics |
| Ian
Glass, M.D. |
206-528-5142 |
Pediatrics |
| James
Ha, Ph.D. |
206-543-2420 |
Psychology |
| R.
Scott Hansen, Ph.D. |
206-543-4184 |
Medical Genetics |
| Anne
Hing, M.D. |
206-616-4668 |
Pediatrics |
| Rodney
Ho, Ph.D. |
206-543-9434 |
Pharmaceutics |
| Marshall S. Horwitz, M.D., Ph.D. |
206-616-4566 |
Genome Sciences |
| Cliff Hume, M.D., Ph.D. |
206-543-5230 |
Otolaryngology/Head and Neck Surgery |
| Charles
Laird, Ph.D. |
206-616-6267 |
Zoology |
| Heather Mefford, M.D., Ph.D. |
206-543-9572 |
Pediatrics |
| Kathleen J. Millen, Ph.D. |
206-884-3225 |
Pediatrics |
| David Morris,
Ph.D. |
206-543-1694 |
Biochemistry |
| Hans
Ochs, M.D. |
206-543-3207 |
Pediatrics |
| Leo
Pallanck, Ph.D. |
206-616-5997 |
Genome Sciences |
| Wendy
Raskind, M.D., Ph.D. |
206-543-3177 |
Medicine |
| Craig
Rubens, M.D., Ph.D. |
206-987-2073 |
Pediatrics |
| C.
Ronald Scott, M.D. |
206-543-3370 |
Pediatrics |
| Stephen
Tapscott, Ph.D. |
206-667-4499 |
Neurology |
| Bruce
Tempel, Ph.D. |
206-616-4693 |
Otolaryngology/Head and Neck Surgery, Pharmacology |
| Eric Turner, M.D., Ph.D. |
206-884-1025 |
Integrative Brain Research |
| Jashvant
Unadkat, Ph.D. |
206-543-9434 |
Pharmaceutics |
| Ellen M. Wijsman, Ph.D. |
206-543-8987 |
Medicine, Biostatistics |
|